LEO Pharma is recalling a batch of Fucidin 250 mg tablets, which was first distributed in July 2023 and has an expiry date of 31 January, 2026, due to out-of-specification results for impurities during routine stability testing.
The drug manufacturer has confirmed that 1,848 packs of this batch (D00993) have been released and distributed, and healthcare professionals have been advised to immediately stop supplying this batch.
They need to quarantine the remaining stock and return it to their supplier.
The tablet's active ingredient is sodium fusidate and is used to treat staphylococcal infections.
Leo Pharma claimed no related adverse event reports or product quality complaints have been received related to this defect.
No further action is required by patients as this is a Pharmacy and Wholesaler level recall, it added.
The MHRA has advised patients to seek medical attention if they experience adverse reactions or have any questions about the medication.
In case of any suspected adverse reactions, they should report via the MHRA Yellow Card scheme, it added.
